1. Home
  2. MNKD vs NAC Comparison

MNKD vs NAC Comparison

Compare MNKD & NAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • NAC
  • Stock Information
  • Founded
  • MNKD 1991
  • NAC 1998
  • Country
  • MNKD United States
  • NAC France
  • Employees
  • MNKD N/A
  • NAC N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • NAC Investment Managers
  • Sector
  • MNKD Health Care
  • NAC Finance
  • Exchange
  • MNKD Nasdaq
  • NAC Nasdaq
  • Market Cap
  • MNKD 1.6B
  • NAC 1.6B
  • IPO Year
  • MNKD 2004
  • NAC N/A
  • Fundamental
  • Price
  • MNKD $4.54
  • NAC $10.72
  • Analyst Decision
  • MNKD Buy
  • NAC
  • Analyst Count
  • MNKD 6
  • NAC 0
  • Target Price
  • MNKD $8.92
  • NAC N/A
  • AVG Volume (30 Days)
  • MNKD 2.2M
  • NAC 307.3K
  • Earning Date
  • MNKD 05-07-2025
  • NAC 01-01-0001
  • Dividend Yield
  • MNKD N/A
  • NAC 4.33%
  • EPS Growth
  • MNKD N/A
  • NAC N/A
  • EPS
  • MNKD 0.10
  • NAC N/A
  • Revenue
  • MNKD $285,504,000.00
  • NAC N/A
  • Revenue This Year
  • MNKD $14.23
  • NAC N/A
  • Revenue Next Year
  • MNKD $14.56
  • NAC N/A
  • P/E Ratio
  • MNKD $45.40
  • NAC N/A
  • Revenue Growth
  • MNKD 43.50
  • NAC N/A
  • 52 Week Low
  • MNKD $3.97
  • NAC $9.32
  • 52 Week High
  • MNKD $7.63
  • NAC $11.21
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 28.12
  • NAC 35.90
  • Support Level
  • MNKD $4.34
  • NAC $10.62
  • Resistance Level
  • MNKD $4.72
  • NAC $10.76
  • Average True Range (ATR)
  • MNKD 0.21
  • NAC 0.18
  • MACD
  • MNKD -0.01
  • NAC -0.03
  • Stochastic Oscillator
  • MNKD 27.03
  • NAC 35.24

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About NAC Nuveen California Quality Municipal Income Fund

Nuveen California Quality Municipal Income Fund is a diversified closed-end management investment company. Its objective is to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal and California state income taxes. It invests majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: